(Q44016534)

29 November 2017

Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children (English)

1 reference

29 November 2017

E-I Grussendorf-Conen

series ordinal

1

1 reference

PubMed ID

12047649

29 November 2017

S Jacobs

series ordinal

2

1 reference

29 November 2017

1 May 2002

1 reference

29 November 2017

Pediatric Dermatology

1 reference

29 November 2017

19

1 reference

29 November 2017

3

1 reference

29 November 2017

263-266

1 reference

What's new in human papillomavirus infection

29 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1470.2002.00083.X

Clinical features and age distribution of patients with HPV 2/27/57-induced common warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1470.2002.00083.X

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1470.2002.00083.X

Topical imiquimod: a review of its use in genital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1470.2002.00083.X

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1470.2002.00083.X

Treatment of genital warts with an immune-response modifier (imiquimod).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1470.2002.00083.X

10.1046/J.1525-1470.2002.00083.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12047649